Literature DB >> 12921952

Altered patterns of T cell cytokine production induced by relapsed pre-B ALL cells.

Gregor S D Reid1, Luke Terrett, Angela J Alessandri, Stacey Grubb, Linda Stork, Nita Seibel, Paul Gaynon, Kirk R Schultz.   

Abstract

Relapse of pediatric acute lymphoblastic leukemia (ALL) remains a significant clinical problem. The graft-versus-leukemia (GVL) effect after hematopoietic stem cell transplantation indicates that immune mechanisms may play a role in the control of ALL blasts. In this study, we analyzed primary diagnostic and relapsed pre-B ALL samples for the surface expression of several molecules implicated in immune responses and for the induction of allogeneic T cell responses. There were no significant differences in the expression of CD11a, CD40, CD80 and CD86 or MHC classes I and II molecules between the diagnostic and relapsed samples. We found no significant differences in the overall ability of diagnostic and relapsed pre-B ALL samples to induce T cell proliferation and cytokine production. However, in the case of T cell responses induced by diagnostic ALL samples, there was excellent correlation between proliferation and production of all cytokines analyzed. In the case of relapsed samples, the only correlation obtained was with IL-5. This observation indicates that the nature of the immune response generated by relapsed ALL cells in an allogeneic setting differs from that obtained with diagnostic samples, suggests a biasing towards a Th2 response may contribute to the evasion of effective immune responses by relapsed ALL.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12921952     DOI: 10.1016/s0145-2126(03)00106-1

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  5 in total

Review 1.  Going back to class I: MHC and immunotherapies for childhood cancer.

Authors:  Kellie B Haworth; Jennifer L Leddon; Chun-Yu Chen; Edwin M Horwitz; Crystal L Mackall; Timothy P Cripe
Journal:  Pediatr Blood Cancer       Date:  2014-12-18       Impact factor: 3.167

Review 2.  New frontiers in pediatric Allo-SCT: novel approaches for children and adolescents with ALL.

Authors:  M A Pulsipher; A S Wayne; K R Schultz
Journal:  Bone Marrow Transplant       Date:  2014-06-16       Impact factor: 5.483

Review 3.  Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease.

Authors:  Valerie I Brown; Alix E Seif; Gregor S D Reid; David T Teachey; Stephan A Grupp
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

4.  HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape.

Authors:  Mariarosaria Conte; Carmela Dell'Aversana; Rosaria Benedetti; Francesca Petraglia; Annamaria Carissimo; Valeria Belsito Petrizzi; Alfonso Maria D'Arco; Ciro Abbondanza; Angela Nebbioso; Lucia Altucci
Journal:  Oncotarget       Date:  2015-01-20

Review 5.  Pediatric precursor B acute lymphoblastic leukemia: are T helper cells the missing link in the infectious etiology theory?

Authors:  Simone Bürgler; David Nadal
Journal:  Mol Cell Pediatr       Date:  2017-05-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.